L. Lee

Statistics

Publications

Citations

132

H-Index

Active since

1985

Affiliations

National Cancer Institute(Current)

L. Lee is an author at National Cancer Institute specializing in tyrosine kinase inhibitor therapy, molecular biology, and insulin-like growth factor receptor signaling.

Publications per year

1985–2005

Publications

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

Joachim Drevs, Ute Zirrgiebel, C. Schmidt-Gersbach et al. · Annals of Oncology · 2005 · 120 citations

Medicine, Oncology, Pharmacology +17

Evidence for the phosphorylation of the type II insulin-like growth factor receptor in cultured cells

Joyce F. Haskell, S. Peter Nissley, Matthew M. Rechler et al. · Biochemical and Biophysical Research Communications · 1985 · 12 citations

Life Sciences, Biochemistry, Molecular Biology +9

1–2 of 2